Rama Phosphates

NSE: RAMAPHOBSE: 524037
Compare with peers
₹ 100.50▼ 3.71 (−3.56%)28 Oct, 03:28 pm IST
Market cap
₹ 344 Cr.
P/E
6.8x
P/B
0.86x
52-week range
96.8 – 217.19
ROE
13%
ROCE
15%
Dividend yield
0.7%
Debt / equity
0.33
Sector
Fertilizers & Agrochemicals
Industry
Fertilizers
Listed on
NSE, BSE

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Fertilizers: 29 companies →

Rama Phosphates against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)6.8 against a typical 12.8: cheaper than most peers (1st = cheapest).6th of 27
  • Sales growth+18.4% against a typical +17.4% from a year earlier.11th of 23
  • Profit growth+6.3% against a typical −2.3% from a year earlier.10th of 22
  • Share price, 3 months−20.9% against a typical −14%.23rd of 25
  • Size₹ 344.2 Cr. market value against a typical ₹ 200.6 Cr. (1st = largest).9th of 21

Credit ratings

Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates

Adequate safety

Rated A- by ICRA
A-
DefaultRiskyModerateSafeVery safe
  • No warnings from the agency.
AgencyCurrent ratingOutlookAs of
ICRA[ICRA]A- Rating Watch with Negative Implications—12 May 2026
Credit rating actions
RatingDetails
12 May 2026
Reaffirmed
[ICRA]A- Rating Watch with Negative Implications—ICRA₹ 168 Cr.
28 Apr 2026
Reaffirmed
[ICRA]A- Rating Watch with Negative Implications—ICRA₹ 168 Cr.
26 Mar 2026
Reaffirmed
[ICRA]A- → [ICRA]A- Rating Watch with Negative Implications—ICRA₹ 136 Cr.
24 Dec 2025
Reaffirmed
[ICRA]A-—ICRA₹ 136 Cr.

Board meetings

Results dates and other board meetings. Full calendar

Details
24 Jul 2026Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
18 May 2026Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
14 Jan 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
14 Oct 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended September 30, 2025, dividend and other business matters
23 Jul 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2025 and other business matters
14 May 2025Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters

Share price

1Y change −50.89%
Volume (shares)Price (₹)
Close price

Financials

Standalone figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales171116186154209180201190246238219225
Expenses166149186148199170184164219214209197
Operating Profit6−32061110172727241028
OPM %3.3%−28%0.1%3.8%5%6%9%14%11%10%4.6%12%
Other Income000000200011
Interest334333442324
Depreciation222222222222
Profit before tax1−38−525514212319723
Tax %7%−21%−53%−4%43%28%61%25%24%27%22%25%
Net Profit1−30−22345161714517
EPS in Rs0.19−8.4−0.660.470.871.031.484.534.883.961.524.82

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
9%
5 Years
9%
3 Years
1%
TTM
19%
Compounded Profit Growth
10 Years
21%
5 Years
4%
3 Years
9%
TTM
92%
Stock Price CAGR
10 Years
15%
5 Years
−6%
3 Years
−1%
TTM
—
Return on Equity
10 Years
10%
5 Years
9%
3 Years
3%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
75%
0 pts in a year
FIIs
0.16%
+0.08 pts in a year
DIIs
0.03%
0 pts in a year
Public
24.81%
−0.08 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 6.8xEPS (12 months) ₹ 15.19Median P/E 8.2x
P/E (times)EPS (₹)

Prices are delayed and for information only. Nothing on this page is investment advice.